Shareholder Class Action

A shareholder class action accusers directors of “<a href="http://www.courthousenews.com/wp-content/uploads/2019/12/Shareholder-CA.pdf"><strong>a massive fraud</strong></a> that has left Akorn — a once-vibrant multibillion-dollar pharmaceutical company — in ruins,” in federal court.

CHICAGO — A shareholder class action accuses directors of “a massive fraud that has left Akorn — a once-vibrant multibillion-dollar pharmaceutical company — in ruins,” in federal court.

Categories / Securities

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.